162 related articles for article (PubMed ID: 3565179)
41. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
[TBL] [Abstract][Full Text] [Related]
42. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
43. [Experimental study on an adriamycin-aluminum complex modified anticancer agent].
Shintomi Y
Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):69-77. PubMed ID: 2738441
[TBL] [Abstract][Full Text] [Related]
44. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
[TBL] [Abstract][Full Text] [Related]
46. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
Suzumori K; Yasui Y; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
[TBL] [Abstract][Full Text] [Related]
47. [Experimental study of chemotherapy of renal cell carcinoma. 1. Combination effect through the use of cell kinetics-directed treatment schedules].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):1-14. PubMed ID: 3577958
[TBL] [Abstract][Full Text] [Related]
48. Transplantation of human renal carcinomas into athymic mice.
Clayman RV; Figenshau RS; Bear A; Limas C
Cancer Res; 1985 Jun; 45(6):2650-3. PubMed ID: 3986801
[TBL] [Abstract][Full Text] [Related]
49. [Chemosensitivity to mitomycin C and cell kinetics of human tumor xenografts serially transplanted into nude mice].
Nakada M
Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):694-704. PubMed ID: 6436678
[TBL] [Abstract][Full Text] [Related]
50. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
51. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
52. Chemosensitivity of human pancreatic cancer cell lines serially transplanted in nude mouse.
Tomikawa M; Kubota T; Takahashi S; Matsuzaki SW; Kitajima M
Anticancer Res; 1998; 18(2A):1059-62. PubMed ID: 9615765
[TBL] [Abstract][Full Text] [Related]
53. Stability of human renal cell carcinomas during long term serial transplantation into nude mice: histopathology, nuclear grade, mitotic rate, and DNA content in thirty tumors.
Knöfel WT; Otto U; Baisch H; Klöppel G
Cancer Res; 1987 Jan; 47(1):221-4. PubMed ID: 3791208
[TBL] [Abstract][Full Text] [Related]
54. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
55. [Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].
Fujita M; Fujita F; Sakamoto Y; Sugimoto T; Shimozuma K; Taguchi T
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1429-37. PubMed ID: 1854213
[TBL] [Abstract][Full Text] [Related]
56. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
57. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
58. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
59. Erythropoietin-induced polycythemia in athymic mice following transplantation of a human renal carcinoma cell line.
Shouval D; Anton M; Galun E; Sherwood JB
Cancer Res; 1988 Jun; 48(12):3430-4. PubMed ID: 3370640
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of anticancer agents in vitro and in vivo using cultured human endometrial carcinoma cells--study of therapeutic index.
Yasui Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):303-6. PubMed ID: 3102652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
